UMI TransVIHMI

Unité Mixte Internationale TransVIHMI

L’UMI 233 étudie principalement les spécificités de l’infection par le VIH au Sud et ses conséquences pour les populations. L’impact du VIH sur les autres endémies infectieuses tropicales fait que le champ des recherches aborde aussi la problématique des co-infections (hépatites, tuberculose) et d’autres maladies tropicales négligées telles que les filarioses et plus récemment l'infection par le virus Ebola. Autour de cette unité thématique, et cela depuis sa création il y a près de 20 ans, l’UMI 233 mène des travaux de recherches transversales pluridisciplinaires associant virologie, parasitologie, clinique, épidémiologie, santé publique et sciences sociales. Si le VIH et les Maladies Associées restent le thème principal de l'unité, l'unité mène des travaux sur les Maladies Tropicales Négligées comme la filariose, l'infection par le virus Ebola et tout récemment l’infection par le virus SARS-CoV-2 .

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

21 to 30 of 63 Results

WHODAS_Loa_Congo_PlosNTD_Dictionnary_Data.tab May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project) Tabular Data - 2.5 KB - 12 Variables, 36 Observations - UNF:6:ui7L6W5QiM700BJWaUsesg== Documentation Data dictionnary
CRF.pdf May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Adobe PDF - 879.3 KB - MD5: de113c80381c87ac2465ec7e903e2e56 Documentation Case report form (PDF, 19 pages).
Data.tab May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Tabular Data - 18.8 KB - 1 Variables, 546 Observations - UNF:6:QDTu5z2Y7xIeanRSu3mpUw== Données Main dataset, pseudoanonymized (text UTF-8, tab-separated values).
LEV-Loa-README.txt May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Plain Text - 3.1 KB - MD5: 17ef164af6d4c1a6c7466501e9c45a83 Documentation Dataset citation, dictionnary and description.
Protocole (french) May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial Adobe PDF - 978.7 KB - MD5: abcbc134d5a6b7e9bd11ac8cfa781362 Documentation Study protocol (PDF, 41 pages).
IVM_SAE_dictionary.tab Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon) Tabular Data - 279 B - 4 Variables, 5 Observations - UNF:6:ltQ5yZeR2M0mG6wjkbhtEA== Documentation Data dictionary
IVM_SAE.tab Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon) Tabular Data - 259.9 KB - 6 Variables, 10506 Observations - UNF:6:tqkmhZPx/qJ/AQogYLZUNw== Data Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment
Loa_EIG_Data_Use_Agreement_Template.docx Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon) MS Word - 13.1 KB - MD5: db84ac6af90cc621a2d17a2ceec01e31 Documentation A template to be filled in and signed by the data requester to access the data
ReadMe.txt Mar 4, 2025 - Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon) Plain Text - 3.3 KB - MD5: 816f0a76ed95e090814e677e0244a758 Documentation Dataset citation, description and terms of use
Incidence_loiasis_Absence.tab Jan 30, 2025 - Replication data for - Incidence of loiasis clinical manifestations in a rural area of the Republic of Congo: results from a longitudinal prospective study (the MorLo project) Tabular Data - 27.4 KB - 13 Variables, 318 Observations - UNF:6:dFCLcW0hIoweFRZXnUre5Q== Data File containing 'Absence' events in long format

WHODAS_Loa_Congo_PlosNTD_Dictionnary_Data.tab

May 23, 2025 - Disability and quality of life assessment using WHODAS-12 items 2.0 and EQ-5D-5L in a rural area endemic for loiasis in the Republic of Congo: a population-based cross-sectional study (the MorLo project)

Tabular Data - 2.5 KB - 12 Variables, 36 Observations -

Documentation

Data dictionnary

CRF.pdf

May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial

Adobe PDF - 879.3 KB -

Documentation

Case report form (PDF, 19 pages).

Data.tab

May 23, 2025 - Replication data for Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial